Overlap between neurodegenerative disorders

Neurodegenerative disorders are characterized by the formation of distinct pathological changes in the brain, including extracellular protein deposits, cellular inclusions, and changes in cell morphology. Since the earliest published descriptions of these disorders, diagnosis has been based on clinicopathological features, namely, the coexistence of a specific clinical profile together with the presence or absence of particular types of lesion. In addition, the molecular profile of lesions has become an increasingly important feature both in the diagnosis of existing disorders and in the description of new disease entities. Recent studies, however, have reported considerable overlap between the clinicopathological features of many disorders leading to difficulties in the diagnosis of individual cases and to calls for a new classification of neurodegenerative disease. This article discusses: (i) the nature and degree of the overlap between different neurodegenerative disorders and includes a discussion of Alzheimer's disease, dementia with Lewy bodies, the fronto‐temporal dementias, and prion disease; (ii) the factors that contribute to disease overlap, including historical factors, the presence of disease heterogeneity, age‐related changes, the problem of apolipoprotein genotype, and the co‐occurrence of common diseases; and (iii) whether the current nosological status of disorders should be reconsidered.

[1]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[2]  F. Tagliavini,et al.  Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain , 1999, Neurology.

[3]  J. Gilbert,et al.  Lewy body and Alzheimer pathology in a family with the amyloid-β precursor protein APP717 gene mutation , 2000, Acta Neuropathologica.

[4]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[5]  A. Kakita,et al.  Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. , 1998, Acta neuropathologica.

[6]  B. Vogt,et al.  Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease , 2004, Acta Neuropathologica.

[7]  G. Utermann Alzheimer's disease. The apolipoprotein E connection. , 1994, Current biology : CB.

[8]  A. Brice Unstable mutations and neurodegenerative disorders , 1998, Journal of Neurology.

[9]  Masanori Kato,et al.  Clinicopathological multiplicity of dementia with Lewy bodies , 1999 .

[10]  A. Mahadevan,et al.  Infantile neuroaxonal dystrophy and giant axonal neuropathy--overlap diseases of neuronal cytoskeletal elements in childhood? , 2000, Clinical neuropathology.

[11]  P. Ince,et al.  Detection of Lewy Bodies in Trisomy 21 (Down's Syndrome) , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[12]  R. Martins,et al.  Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. , 2003, Brain : a journal of neurology.

[13]  A. Hakim,et al.  Dementia in Parkinson disease , 1979, Neurology.

[14]  D. Dickson,et al.  Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease , 1991, Neurology.

[15]  Charles Duyckaerts,et al.  Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. , 1993, Neurobiology of aging.

[16]  R. Levy,et al.  The Lewy-Body Variant of Alzheimer's Disease , 1993, British Journal of Psychiatry.

[17]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[18]  P. Lantos,et al.  Cortical Lewy body dementia: clinical features and classification. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[19]  D. Neary,et al.  Dementia of frontal lobe type. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[20]  Hans Förstl,et al.  Pick und die fokalen Hirnatrophien , 1994 .

[21]  J. Trojanowski,et al.  Analysis of tau haplotypes in Pick’s disease , 2002, Neurology.

[22]  F. Crawford,et al.  Genetic and molecular advances in Alzheimer's disease. , 1993, Trends in neurosciences.

[23]  Colin L. Masters,et al.  α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores , 1999, Neuroscience Letters.

[24]  B. Chesebro BSE and Prions: Uncertainties About the Agent , 1998, Science.

[25]  D. Dickson,et al.  Neurodegenerative disorders with extensive tau pathology: A comparative study and review , 1996, Annals of neurology.

[26]  E. Agardh,et al.  (3H)-muscimol, (3H)-nipecotic acid and (3H)-isoguvacine as autoradiographic markers for GABA neurotransmission , 2005, Journal of Neural Transmission.

[27]  R. Petersen,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[28]  D. Dickson,et al.  Phenotypic Variability of Gerstmann-Straussler-Scheinker Disease is Associated with Prion Protein Heterogeneity , 1998, Journal of neuropathology and experimental neurology.

[29]  R. Mayer,et al.  Ubiquitin in Neurodegenerative Diseases , 1993, Brain pathology.

[30]  Mann,et al.  Amyloid β protein (Aβ) deposition in dementia with Lewy bodies: predominance of Aβ42(43) and paucity of Aβ40 compared with sporadic Alzheimer’s disease , 1998 .

[31]  N. Quinn,et al.  [Multiple system atrophy with Lewy bodies]. , 1995, Revue neurologique.

[32]  L. Hakamies,et al.  [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.

[33]  J. Brion,et al.  Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. , 1995, The American journal of pathology.

[34]  J D Fenwick,et al.  Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD , 2001, Neurology.

[35]  P. Lantos,et al.  Quantitative variations in the pathology of 11 cases of variant Creutzfeldt-Jakob disease (vCJD). , 2002, Pathophysiology : the official journal of the International Society for Pathophysiology.

[36]  S. Love,et al.  Alz-50, Ubiquitin and Tau Immunoreactivity of Neurofibrillary Tangles, Pick Bodies and Lewy Bodies , 1988, Journal of neuropathology and experimental neurology.

[37]  T D Bird,et al.  Neuropathological heterogeneity in Alzheimer’s disease: A study of 80 cases using principal components analysis , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.

[38]  P. Lantos,et al.  The spatial patterns of prion protein deposits in Creutzfeldt–Jakob disease: comparison with β-amyloid deposits in Alzheimer's disease , 2001, Neuroscience Letters.

[39]  Satoshi Minoshima,et al.  Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation , 2001, Annals of neurology.

[40]  C. Masters,et al.  Gerstmann–Sträussler–Scheinker syndrome,fatal familial insomnia, and kuru: a review ofthese less common human transmissiblespongiform encephalopathies , 2001, Journal of Clinical Neuroscience.

[41]  P. Brown,et al.  Coexistence of Creutzfeldt‐Jakob disease and Alzheimer's disease in the same patient , 1990, Neurology.

[42]  Hans Förstl Alzheimer's disease: the size of the problem, clinical manifestation and heterogeneity. , 1998, Journal of neural transmission. Supplementum.

[43]  Masanori Kato,et al.  An autopsied case of Down syndrome with Alzheimer pathology and α‐synuclein immunoreactivity , 1999 .

[44]  I Litvan,et al.  Progressive supranuclear palsy and corticobasal degeneration. , 2011 .

[45]  R. Armstrong,et al.  The identification of pathological subtypes of Alzheimer's disease using cluster analysis , 2004, Acta Neuropathologica.

[46]  J. Trojanowski,et al.  Strategies for Improving the Postmortem Neuropathological Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[47]  J. Price,et al.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.

[48]  A. Dürr,et al.  Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology , 2000, European Journal of Human Genetics.

[49]  Hans Förstl,et al.  Diagnostic confirmation, severity, and subtypes of Alzheimer's disease , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[50]  E. Perry,et al.  Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. , 1994, Dementia.

[51]  K. Beyreuther,et al.  Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within kuru plaques not specific to Alzheimer's disease. , 1991, The American journal of pathology.

[52]  I. Shoulson,et al.  Coexistence of Huntington’s disease and familial amyotrophic lateral sclerosis: case presentation , 1996, Acta Neuropathologica.

[53]  D. Dickson,et al.  Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration , 1996, Journal of neuropathology and experimental neurology.

[54]  Kyoko Suzuki,et al.  Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease , 1996, Journal of the Neurological Sciences.

[55]  S. Hirai,et al.  Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition , 2004, Acta Neuropathologica.

[56]  Florence Pasquier,et al.  Early diagnosis of dementia: neuropsychology , 1999, Journal of Neurology.

[57]  J. Schneider,et al.  Regional Variation in the Distribution of Apolipoprotein E and Aβ in Alzheimer's Disease , 1995 .

[58]  S. Kashiwagi,et al.  Current status and controversies in the inhalation protocols for the Xenon CT CBF method , 1996, Acta neurologica Scandinavica. Supplementum.

[59]  A. Pick Über einen weiteren Symptomenkomplex im Rahmen der Dementia senilis, bedingt durch umschriebene stärkere Hirnatrophie (gemischte Apraxie). , 1906 .

[60]  J. Poirier,et al.  Apolipoprotein E, Plaques, Tangles and Cholinergic Dysfunction in Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[61]  D. Mann,et al.  Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome , 1990, Neuroscience Letters.

[62]  P. Lantos,et al.  Beta-Amyloid Deposition in the Temporal Lobe of Patients with Dementia with Lewy Bodies: Comparison with Non-Demented Cases and Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.

[63]  B. Steinhoff,et al.  Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[64]  P. Lantos,et al.  What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? , 2001, Neuropathology : official journal of the Japanese Society of Neuropathology.

[65]  T. Kitamoto,et al.  The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration , 1992, Acta Neuropathologica.

[66]  S H Appel,et al.  A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease , 1981, Annals of neurology.

[67]  L. Deecke,et al.  [123I]β‐CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration , 2000, Movement disorders : official journal of the Movement Disorder Society.

[68]  M. Mullan,et al.  Genetics and molecular advances in Alzheimer's disease , 1993, Trends in Neurosciences.

[69]  J. Trojanowski,et al.  Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. , 1996, The American journal of pathology.

[70]  B. Steinhoff,et al.  Current clinical diagnosis in Creutzfeldt‐Jakob disease: Identification of uncommon variants , 2000, Annals of neurology.

[71]  J. Trojanowski,et al.  The Neuropathology of a Chromosome 17-Linked Autosomal Dominant Parkinsonism and Dementia (“Pallido-Ponto-Nigral Degeneration”) , 1998, Journal of neuropathology and experimental neurology.

[72]  P. Lantos,et al.  The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. , 1994, Brain : a journal of neurology.

[73]  D. Dickson,et al.  Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy. , 1996, The American journal of pathology.

[74]  S. Duckett,et al.  Origins of the Creutzfeldt and Jakob concept. , 1999, Journal of the history of the neurosciences.

[75]  Hans Förstl The Lewy body variant of Alzheimer’s disease: clinical, pathophysiological and conceptual issues , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[76]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[77]  I Vuillaume,et al.  Simple Nonisotopic Assays for Detection of (CAG)n Repeats Expansions Associated With Seven Neurodegenerative Disorders , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[78]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging , 1999, Journal of neurology, neurosurgery, and psychiatry.

[79]  H. Möller,et al.  The case described by Alois Alzheimer in 1911 , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[80]  A. Kertesz,et al.  Arnold Pick and German neuropsychiatry in Prague. , 1996, Archives of neurology.

[81]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[82]  L. Gustafson Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis , 1998 .

[83]  D. Perl,et al.  Alzheimer's disease and parkinson's disease: Distinct entities or extremes of a spectrum of neurodegeneration? , 1998, Annals of neurology.

[84]  M. Palmer,et al.  Prion diseases in humans and their relevance to other neurodegenerative diseases. , 1993, Dementia.

[85]  W. Kirschbaum Jakob-Creutzfeldt disease : spastic pseudosclerosis, A. Jakob; Heidenhain syndrome; subacute spongiform encephalopathy , 1968 .

[86]  Jeffrey L. Cummings,et al.  Cognitive and behavioral heterogeneity in Alzheimer’s disease: seeking the neurobiological basis , 2000, Neurobiology of Aging.

[87]  D. Gajdusek,et al.  Mixed features of Alzheimer disease and Creutzfeldt-Jakob disease in a family with a presenilin 1 mutation in chromosome 14 , 1996 .

[88]  A Brun,et al.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. , 1987, Archives of gerontology and geriatrics.

[89]  F. Tagliavini,et al.  Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques , 1989, Neuroscience Letters.

[90]  P. Hof,et al.  Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases , 2004, Acta Neuropathologica.

[91]  J. Foncin,et al.  [Association of Alzheimer's disease and Creutzfeldt-Jakob's disease (author's transl)]. , 1977, Acta neurologica Belgica.

[92]  H. Vinters Cerebral amyloid angiopathy and alzheimer's disease: two entities or one? , 1992, Journal of the Neurological Sciences.

[93]  H. Chui,et al.  Clinical subtypes of dementia of the Alzheimer type , 1985, Neurology.

[94]  D W Dickson,et al.  Neuropathology of Alzheimer's disease and other dementias. , 2001, Clinics in geriatric medicine.

[95]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[96]  P. Lantos,et al.  Laminar distribution of Pick bodies, Pick cells and Alzheimer disease pathology in the frontal and temporal cortex in Pick’s disease , 1999, Neuropathology and applied neurobiology.

[97]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[98]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[99]  D. Neary Dementia of Frontal Lobe Type , 1990, Journal of the American Geriatrics Society.

[100]  J. Touchon,et al.  Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical sub-types? , 1992, Journal of clinical epidemiology.

[101]  The spatial patterns of β/A4 deposit subtypes in Down's syndrome , 1994 .

[102]  A. Roses,et al.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.

[103]  P. Blumbergs,et al.  Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease , 1995, Acta Neuropathologica.

[104]  M. Hutton,et al.  Phenotypic correlations in FTDP-17 , 2001, Neurobiology of Aging.

[105]  I. McKeith,et al.  A Comparison of Medial and Lateral Temporal Lobe Atrophy in Dementia with Lewy Bodies and Alzheimer’s Disease: Magnetic Resonance Imaging Volumetric Study , 2001, Dementia and Geriatric Cognitive Disorders.

[106]  H. Möller,et al.  Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis , 1997, Neurogenetics.

[107]  P. Lantos,et al.  Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration? , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.

[108]  C. Duyckaerts,et al.  Apolipoprotein E allele ε4 is linked to increased deposition of the amyloid β-peptide (A-β) in cases with or without Alzheimer's disease , 1994, Neuroscience Letters.

[109]  R. Armstrong β-Amyloid Plaques: Stages in Life History or Independent Origin? , 1998, Dementia and Geriatric Cognitive Disorders.

[110]  T. Pillot,et al.  Molecular basis of Alzheimer’s disease , 2007, Molecular Biology.

[111]  M. Gaviria,et al.  [Fronto-temporal dementia]. , 2000, Actas espanolas de psiquiatria.

[112]  A. Aguzzi,et al.  Prion research: the next frontiers , 1997, Nature.

[113]  C. Heizmann,et al.  Parvalbumin-immunoreactive neurons in the cortex in Pick's disease , 1991, Journal of Neurology.

[114]  S. Sorbi,et al.  Genetic risk factors in familial Alzheimer's disease , 2001, Mechanisms of Ageing and Development.

[115]  J. Lowe,et al.  Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. , 1998, Neuropathology and applied neurobiology.

[116]  R. Armstrong,et al.  Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. , 1995, Dementia.

[117]  P. Lantos,et al.  β-Amyloid (Aβ) deposition in the medial temporal lobe of patients with dementia with Lewy bodies , 1997, Neuroscience Letters.

[118]  C. van Broeckhoven,et al.  Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin 1 missense substitution and a prion protein gene insertion , 2000, Journal of Neurology.

[119]  Ian G. McKeith,et al.  Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions , 2003, Neuroscience Letters.

[120]  K. Jellinger,et al.  Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease , 1998, Acta Neuropathologica.

[121]  B. Steinhoff,et al.  How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. , 1999, Brain : a journal of neurology.

[122]  G. Glenner,et al.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.

[123]  P Falkai,et al.  Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores. , 1999, Neuroscience letters.

[124]  D. Knopman,et al.  An overview of common non-Alzheimer dementias. , 2001, Clinics in geriatric medicine.

[125]  H. Möller,et al.  Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D. , 1998, Neurogenetics.

[126]  M. Gearing,et al.  Corticobasal degeneration , 1997, Neurology.

[127]  J. Hardy,et al.  Lewy bodies in Alzheimer's disease in which the primary lesion is a mutation in the amyloid precursor protein , 1994, Neuroscience Letters.

[128]  J. Morris,et al.  The nosology of dementia. , 2000, Neurologic clinics.

[129]  M. Rossor Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. , 1981, British medical journal.

[130]  A. Lang,et al.  Motor neuron disease‐inclusion dementia presenting as cortical‐basal ganglionic degeneration , 1999, Movement disorders : official journal of the Movement Disorder Society.

[131]  R. van Reekum,et al.  Dementia with Lewy bodies in Down's syndrome , 2001, International journal of geriatric psychiatry.

[132]  W. Spielmeyer Die Histopathologische Forschung in der Psychiatrie , 1922, Klinische Wochenschrift.

[133]  E. Kosno-Kruszewska,et al.  Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study. , 2001, Folia neuropathologica.

[134]  Y. Ihara,et al.  Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population. , 1995, Brain research. Molecular brain research.

[135]  I Litvan,et al.  What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? , 1996, Brain : a journal of neurology.

[136]  Hitoshi Takahashi,et al.  Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy , 1998, Acta Neuropathologica.

[137]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[138]  A. Alzheimer Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .

[139]  K. Watabe,et al.  Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain‐stem in Lewy body disease , 1993, Acta pathologica japonica.

[140]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[141]  K. Jellinger,et al.  Neuropathology of Alzheimer's disease: a critical update. , 1998, Journal of neural transmission. Supplementum.

[142]  K. Blennow,et al.  Clinical subgroups of the Alzheimer syndrome , 1996, Acta neurologica Scandinavica. Supplementum.

[143]  P. Righetti,et al.  Two‐dimensional mapping of three phenotype‐associated isoforms of the prion protein in sporadic Creutzfeldt‐Jakob disease , 2002, Electrophoresis.

[144]  H. Kretzschmar,et al.  Die neuropathologische Diagnostik neurodegenerativer und demenzieller Krankheiten , 2000, Der Pathologe.

[145]  Charles Duyckaerts,et al.  Subtypes and differential laminar distributions of βA4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases , 2004, Acta Neuropathologica.

[146]  R. Mantegna,et al.  Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). , 1995, Proceedings of the National Academy of Sciences of the United States of America.